TELA Bio (TELA) Debt to Equity (2018 - 2026)
TELA Bio has reported Debt to Equity over the past 7 years, most recently at $8.82 for Q4 2025.
- For Q4 2025, Debt to Equity rose 510.04% year-over-year to $8.82; the TTM value through Dec 2025 reached $8.82, up 510.04%, while the annual FY2025 figure was $8.82, 510.04% up from the prior year.
- Debt to Equity for Q4 2025 was $8.82 at TELA Bio, down from $26.65 in the prior quarter.
- Over five years, Debt to Equity peaked at $26.65 in Q3 2025 and troughed at -$25.69 in Q2 2022.
- A 5-year average of $3.24 and a median of $2.21 in 2025 define the central range for Debt to Equity.
- On a YoY basis, Debt to Equity climbed as much as 1314.87% in 2024 and fell as far as 594.44% in 2024.
- Year by year, Debt to Equity stood at $1.57 in 2021, then skyrocketed by 78.08% to $2.79 in 2022, then fell by 23.1% to $2.15 in 2023, then plummeted by 32.66% to $1.45 in 2024, then skyrocketed by 510.04% to $8.82 in 2025.
- Business Quant data shows Debt to Equity for TELA at $8.82 in Q4 2025, $26.65 in Q3 2025, and $4.51 in Q2 2025.